Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
Iain Riddell IAIN RIDDELL, the man responsible for bringing monitor farms to Scotland, is retiring after more than 40 years at SAC Consulting, part of Scotland’s Rural College. Mr Riddell, who steps down from his role as Business Development Manager this week, first explored the idea of monitor farms while on holiday in New Zealand in 1998. Two years later, he won funding for a Farmers Club Charitable Trust study tour to report on the farms with the hope of replicating the idea back home. Since then, SAC Consulting has facilitated more than 40 monitor farms throughout Scotland, showcasing innovation in dairy, sheep, beef and arable farming and, in 2006, Iain’s work was recognised with an Inverarity Prize for Business Innovation.
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map
ACCESSWIRE
11 May 2021, 20:05 GMT+10
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
(1)
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
The project commenced in 2017, is designed to deliver a gene and protein expression map of healthy hair follicle cells expected to be critically important to improving key components of the manufacturing, regulatory, and clinical profile of RepliCel s cell therapy products.
Professor Alastair Gray
Biography
Alastair Gray is Professor of Health Economics in the Nuffield Department of Population Health, University of Oxford. He has previously held academic appointments at the University of Aberdeen, the Open University and the London School of Hygiene and Tropical Medicine.
His main research interests concern the use of economic evaluation to aid decision-making. He has worked across many different disease areas, with particular interests in diabetes and cardiovascular disease.
As a researcher he has helped to evaluate changes to the breast and bowel cancer screening programmes. As a member of the UK NSC since 2015, he provides advice and expertise on health economics and disease modelling, with respect both to the existing screening programmes and to proposals for new programmes.